1- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
2- HEIDENREICH, Paul A. et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, v. 79, n. 17, p. e263-e421, 2022.
3- SHIBATA, Marcelo C.; FLATHER, Marcus D.; WANG, Duolao. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. European Journal of Heart Failure, v. 3, n. 3, p. 351-357, 2001.
4- BRIASOULIS, Alexandros; PALLA, Mohan; AFONSO, Luis. Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure. American Journal of Cardiology, v. 115, n. 8, p. 1111-1115, 2015.
5- Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA el al. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. 2002 Oct 22;106(17):2194-9.
6- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999 Jun 12;353(9169):2001-7. PMID: 10376614.
7- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a Randomised Trial. Lancet. 1999 Jan 2;353(9146):9-13. PMID: 10023943.
8- Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Brouse S, et al. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Apr 16;83(15):1444-1488. doi: 10.1016/j.jacc.2023.12.024. Epub 2024 Mar 8. PMID: 38466244.
Exclusividade médica
